7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Accelerate Diagnostics, Inc
(NASDAQ:AXDX) 

AXDX stock logo

Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibilit...

Founded: 1982
Full Time Employees: 275
Sector: Healthcare
Industry: Diagnostics & Research

Share this website to your friends
Accelerate Diagnostics Days Payable Outstanding ttm (DPO)
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 026.5953.1879.76106.35132.94159.53186.12
Accelerate Diagnostics Days Receivable Outstanding ttm (DSO)
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 011.5823.1634.7446.3257.969.4881.06
Accelerate Diagnostics Days Inventory Outstanding ttm (DIO)
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 031.5663.1394.69126.26157.82189.38220.95
Accelerate Diagnostics Op Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -42.98-36.84-30.7-24.56-18.42-12.28-6.140
Accelerate Diagnostics Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -43.22-37.05-30.87-24.7-18.52-12.35-6.170
Accelerate Diagnostics Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 03.987.9711.9515.9419.9223.9127.89
Accelerate Diagnostics P/S ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 02.14.196.298.3910.4812.5814.67
Accelerate Diagnostics (GAAP) P/E ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -10.58-9.07-7.56-6.04-4.53-3.02-1.510
Accelerate Diagnostics P/B ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -18.3-15.69-13.07-10.46-7.84-5.23-2.610
No extra charts and metrics for this ticker.